The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either not available — or if it is, it costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag.
Boreal forests move north as Arctic ice melts
The Current Introduces: The Pornhub Empire: Understood
What’s behind Putin’s re-election as Russia’s president
Feeling invisible? You might be languishing
Tennessee high schoolers say they’ve cracked a 1980s cold case
Haitian-led solutions to the country’s political crisis
Helping Nunavut elders age in their own communities
U.S. mulls speed limiting tech in cars
U.S. threatens TikTok ban over company’s links to China
Why this woman posted fake reviews online
Aid groups push to get food into Gaza as crisis worsens
Man's court challenge of adult daughter's MAID approval raises decision-making questions
Ozempic’s possibilities — and the unintended consequences
Former police officer says MDMA, therapy changed his life
Haiti’s prime minister announces resignation amid chaos in capital
Why we remember a podcast — but not where we listened to it
Oregon reversing course on drug decriminalization as overdose deaths spike
Scientists are matchmaking queen conches in Florida
Why a Canadian military vet started a humanitarian organization in Ukraine
How PornHub became an internet empire
Create your
podcast in
minutes
It is Free
Front Burner
Vinyl Cafe
Ideas
Someone Knows Something
Under the Influence with Terry O’Reilly